FR2723846B1 - Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble - Google Patents

Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble

Info

Publication number
FR2723846B1
FR2723846B1 FR9410256A FR9410256A FR2723846B1 FR 2723846 B1 FR2723846 B1 FR 2723846B1 FR 9410256 A FR9410256 A FR 9410256A FR 9410256 A FR9410256 A FR 9410256A FR 2723846 B1 FR2723846 B1 FR 2723846B1
Authority
FR
France
Prior art keywords
administration
active substance
solid pharmaceutical
pharmaceutical form
liquid active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9410256A
Other languages
English (en)
Other versions
FR2723846A1 (fr
Inventor
Rosa Martani
Maryvonne Woiltock Barbero
Vu Dominique Le
Alain Gilles Demichelis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HI PHARMTECH
Original Assignee
HI PHARMTECH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HI PHARMTECH filed Critical HI PHARMTECH
Priority to FR9410256A priority Critical patent/FR2723846B1/fr
Priority to PCT/FR1995/001102 priority patent/WO1996005864A1/fr
Publication of FR2723846A1 publication Critical patent/FR2723846A1/fr
Application granted granted Critical
Publication of FR2723846B1 publication Critical patent/FR2723846B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9410256A 1994-08-24 1994-08-24 Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble Expired - Lifetime FR2723846B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9410256A FR2723846B1 (fr) 1994-08-24 1994-08-24 Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble
PCT/FR1995/001102 WO1996005864A1 (fr) 1994-08-24 1995-08-21 Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410256A FR2723846B1 (fr) 1994-08-24 1994-08-24 Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble

Publications (2)

Publication Number Publication Date
FR2723846A1 FR2723846A1 (fr) 1996-03-01
FR2723846B1 true FR2723846B1 (fr) 1997-06-13

Family

ID=9466469

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9410256A Expired - Lifetime FR2723846B1 (fr) 1994-08-24 1994-08-24 Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble

Country Status (2)

Country Link
FR (1) FR2723846B1 (fr)
WO (1) WO1996005864A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2278325A1 (fr) * 1974-07-19 1976-02-13 Beecham Group Ltd Complexe renfermant un antibiotique
JPS5854799B2 (ja) * 1980-05-08 1983-12-06 株式会社 林原生物化学研究所 グリコシルビタミンの製造方法
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
FR2676364B1 (fr) * 1991-05-17 1993-09-10 Lafon Labor Composition pharmaceutique a base de derives d'aminobutanone.

Also Published As

Publication number Publication date
FR2723846A1 (fr) 1996-03-01
WO1996005864A1 (fr) 1996-02-29

Similar Documents

Publication Publication Date Title
FR2508318B1 (fr) Bandage pour l'administration d'une substance pharmaceutique
FR2734483B1 (fr) Forme d'administration pharmaceutique comprenant de l'oxybutynine
FR2732223B1 (fr) Composition pharmaceutique pour administration transdermique
FR2598319B1 (fr) Forme posologique pour delivrer une composition de medicament a un milieu d'utilisation
FR2774591B1 (fr) Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
FR11C0007I2 (fr) Composition pharmaceutique stabilisee a l'aide d'un agent de base
FR2565829B1 (fr) Dispositif pour l'administration des medicaments sous forme de poudres
BE896205A (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
DZ2666A1 (fr) Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
FR2630912B1 (fr) Composition permettant d'administrer un medicament sous forme de gelules, d'une poudre ou d'un liquide
DZ2675A1 (fr) Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant.
IT9020944A0 (it) Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
FR2688405B1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
FR2701708B1 (fr) Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2686064B1 (fr) Conteneur pour la consommation d'une dose de produit liquide.
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
FR2727609B1 (fr) Ensemble de distribution pour l'application d'un produit de consistance liquide a pateuse
FR2570602B1 (fr) Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre
FR2723846B1 (fr) Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble
FR2712511B1 (fr) Cartouche pour la préparation d'acides nucléiques purifiés.
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2764821B1 (fr) Dispositif de dosage par introduction dans un liquide d'un reactif sous forme de galets
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
FR2723317B1 (fr) Utilisation d'antagonistes de la neurotensine pour la preparation de medicaments diuretiques
FR2634825B1 (fr) Pompe a precompression pour la diffusion d'un liquide

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
CD Change of name or company name
GC Lien (pledge) constituted

Effective date: 20140519

RG Lien (pledge) cancelled

Effective date: 20160226